337 related articles for article (PubMed ID: 8626455)
21. Oxidized low density lipoprotein displaces endothelial nitric-oxide synthase (eNOS) from plasmalemmal caveolae and impairs eNOS activation.
Blair A; Shaul PW; Yuhanna IS; Conrad PA; Smart EJ
J Biol Chem; 1999 Nov; 274(45):32512-9. PubMed ID: 10542298
[TBL] [Abstract][Full Text] [Related]
22. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities.
Razani B; Engelman JA; Wang XB; Schubert W; Zhang XL; Marks CB; Macaluso F; Russell RG; Li M; Pestell RG; Di Vizio D; Hou H; Kneitz B; Lagaud G; Christ GJ; Edelmann W; Lisanti MP
J Biol Chem; 2001 Oct; 276(41):38121-38. PubMed ID: 11457855
[TBL] [Abstract][Full Text] [Related]
23. Colocalization of eNOS and the catalytic subunit of PKA in endothelial cell junctions: a clue for regulated NO production.
Heijnen HF; Waaijenborg S; Crapo JD; Bowler RP; Akkerman JW; Slot JW
J Histochem Cytochem; 2004 Oct; 52(10):1277-85. PubMed ID: 15385574
[TBL] [Abstract][Full Text] [Related]
24. The first 35 amino acids and fatty acylation sites determine the molecular targeting of endothelial nitric oxide synthase into the Golgi region of cells: a green fluorescent protein study.
Liu J; Hughes TE; Sessa WC
J Cell Biol; 1997 Jun; 137(7):1525-35. PubMed ID: 9199168
[TBL] [Abstract][Full Text] [Related]
25. Dynamin mediates caveolar sequestration of muscarinic cholinergic receptors and alteration in NO signaling.
Dessy C; Kelly RA; Balligand JL; Feron O
EMBO J; 2000 Aug; 19(16):4272-80. PubMed ID: 10944110
[TBL] [Abstract][Full Text] [Related]
26. Modulation of the endothelial nitric-oxide synthase-caveolin interaction in cardiac myocytes. Implications for the autonomic regulation of heart rate.
Feron O; Dessy C; Opel DJ; Arstall MA; Kelly RA; Michel T
J Biol Chem; 1998 Nov; 273(46):30249-54. PubMed ID: 9804784
[TBL] [Abstract][Full Text] [Related]
27. Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis.
Sonveaux P; Martinive P; DeWever J; Batova Z; Daneau G; Pelat M; Ghisdal P; Grégoire V; Dessy C; Balligand JL; Feron O
Circ Res; 2004 Jul; 95(2):154-61. PubMed ID: 15205364
[TBL] [Abstract][Full Text] [Related]
28. Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity.
Ju H; Zou R; Venema VJ; Venema RC
J Biol Chem; 1997 Jul; 272(30):18522-5. PubMed ID: 9228013
[TBL] [Abstract][Full Text] [Related]
29. Muscarinic cholinergic signaling in cardiac myocytes: dynamic targeting of M2AChR to sarcolemmal caveolae and eNOS activation.
Feron O; Han X; Kelly RA
Life Sci; 1999; 64(6-7):471-7. PubMed ID: 10069512
[TBL] [Abstract][Full Text] [Related]
30. Caveolae compartmentalization of heme oxygenase-1 in endothelial cells.
Kim HP; Wang X; Galbiati F; Ryter SW; Choi AM
FASEB J; 2004 Jul; 18(10):1080-9. PubMed ID: 15226268
[TBL] [Abstract][Full Text] [Related]
31. Mutagenesis of palmitoylation sites in endothelial nitric oxide synthase identifies a novel motif for dual acylation and subcellular targeting.
Robinson LJ; Michel T
Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11776-80. PubMed ID: 8524847
[TBL] [Abstract][Full Text] [Related]
32. NOSIP, a novel modulator of endothelial nitric oxide synthase activity.
Dedio J; König P; Wohlfart P; Schroeder C; Kummer W; Müller-Esterl W
FASEB J; 2001 Jan; 15(1):79-89. PubMed ID: 11149895
[TBL] [Abstract][Full Text] [Related]
33. Dynamic association of nitric oxide downstream signaling molecules with endothelial caveolin-1 in rat aorta.
Linder AE; McCluskey LP; Cole KR; Lanning KM; Webb RC
J Pharmacol Exp Ther; 2005 Jul; 314(1):9-15. PubMed ID: 15778264
[TBL] [Abstract][Full Text] [Related]
34. Endothelial nitric oxide synthase and caveolin-1 are co-localized in sinusoidal endothelial fenestrae.
Yokomori H; Oda M; Ogi M; Kamegaya Y; Tsukada N; Ishii H
Liver; 2001 Jun; 21(3):198-206. PubMed ID: 11422783
[TBL] [Abstract][Full Text] [Related]
35. The ins and outs of caveolar signaling. m2 muscarinic cholinergic receptors and eNOS activation versus neuregulin and ErbB4 signaling in cardiac myocytes.
Feron O; Zhao YY; Kelly RA
Ann N Y Acad Sci; 1999 Jun; 874():11-9. PubMed ID: 10415516
[TBL] [Abstract][Full Text] [Related]
36. The calcium channel blocker amlodipine promotes the unclamping of eNOS from caveolin in endothelial cells.
Batova S; DeWever J; Godfraind T; Balligand JL; Dessy C; Feron O
Cardiovasc Res; 2006 Aug; 71(3):478-85. PubMed ID: 16814758
[TBL] [Abstract][Full Text] [Related]
37. Functional interaction of caveolin-1 and eNOS in myocardial capillary endothelium revealed by immunoelectron microscopy.
Reiner M; Bloch W; Addicks K
J Histochem Cytochem; 2001 Dec; 49(12):1605-10. PubMed ID: 11724908
[TBL] [Abstract][Full Text] [Related]
38. Endothelial nitric oxide synthase and its negative regulator caveolin-1 localize to distinct perinuclear organelles.
Govers R; van der Sluijs P; van Donselaar E; Slot JW; Rabelink TJ
J Histochem Cytochem; 2002 Jun; 50(6):779-88. PubMed ID: 12019294
[TBL] [Abstract][Full Text] [Related]
39. Trafficking of endothelial nitric-oxide synthase in living cells. Quantitative evidence supporting the role of palmitoylation as a kinetic trapping mechanism limiting membrane diffusion.
Sowa G; Liu J; Papapetropoulos A; Rex-Haffner M; Hughes TE; Sessa WC
J Biol Chem; 1999 Aug; 274(32):22524-31. PubMed ID: 10428829
[TBL] [Abstract][Full Text] [Related]
40. ERbeta has nongenomic action in caveolae.
Chambliss KL; Yuhanna IS; Anderson RG; Mendelsohn ME; Shaul PW
Mol Endocrinol; 2002 May; 16(5):938-46. PubMed ID: 11981029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
